Knight Therapeutics Inc (04K:F) Annual Income Statement ()
04K:F Quarterly Financials ()
Frequently Asked Questions About Knight Therapeutics Inc (04K:F) Stock
Knight Therapeutics Inc's (04K:F) last reported annual revenue was EUR 328.20 Million.
Knight Therapeutics Inc's (04K:F) annual revenue growth rate based on the revenue reported in the past 5 years is : 92.24%
Knight Therapeutics Inc's(04K:F) is not profitable as of its last reported annual financials.
The net profit margin for Knight Therapeutics Inc's(04K:F) from its laster reported year is -5.13%
The return on equity (ROE) for Knight Therapeutics Inc's(04K:F) from its last reported annual financials is : -2.14%
The return on assets (ROA) for Knight Therapeutics Inc's(04K:F) from its last reported annual financials is : 0.40%
The return on invested capital (ROIC) for Knight Therapeutics Inc's(04K:F) from its last reported annual financials is : 0.75%
The Debt to Equity ratio for Knight Therapeutics Inc's(04K:F) from its last reported annual financials is : 5.89%
The dividend yield for Knight Therapeutics Inc's(04K:F) from its laster reported year is 0.00%
Knight Therapeutics Inc's(04K:F) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 04K:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
